Log In
BCIQ
Print this Print this
 

CMV-IGIV (CytoGam)

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionPolyclonal antibody against cytomegalovirus (CMV)
Molecular Target Not available
Mechanism of ActionBinds viral antigens; Antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentMarketed
Standard IndicationCytomegalovirus (CMV)
Indication DetailsPrevent congenital transmission of CMV; Prevent cytomegalovirus (CMV) disease in kidney and other organ transplant; Prevent cytomegalovirus (CMV) infection in liver transplant
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today